Oncostatin M-mediated transcriptional suppression of the c-myc gene in breast cancer cells

Cancer Research

Volumn 57, Issue 11, 1997, Pages 2223-2228

  Spence, Michael J ^a,b   Vestal, Robert E ^a,b,c   Liu, Jingwen ^a,b  

^a Boise VA Medical Center   (United States)

^b St Luke's Mountain States Tumor Institute   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DACTINOMYCIN; ONCOSTATIN M;

ARTICLE; BREAST CANCER; DNA SYNTHESIS; DOSE TIME EFFECT RELATION; DOWN REGULATION; GENE EXPRESSION; GENE REPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; ONCOGENE C MYC; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

ANTINEOPLASTIC AGENTS; BLOTTING, NORTHERN; BREAST NEOPLASMS; CARCINOMA; DACTINOMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; HUMANS; NUCLEIC ACID SYNTHESIS INHIBITORS; ONCOSTATIN M; PEPTIDES; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0030925698     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Zarling, J. M., Shoyab, M., Marquardt, H., Hanson, M. B., Lioubin, M. N., and Todaro, G. J. Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells. Proc. Natl. Acad. Sci. USA, 83: 9739-9743, 1986.
2. Brown, T. J., Lioubin, M. N., and Marquardt, H. Purification and characterization of cytostatic lymphokines produced by activated human T-lymphocytes: synergistic antiproliferative activity of transforming growth factor β1, interferon γ, and oncostatin M for human melanoma cells. J. Immunol., 139: 2977-2983, 1987.
3. Grove, R. I., Mazzucco, C., Allegretto, N., Kiener, P. A., Spitalny, G., Radka, S. F., Shoyab, M., Antonaccio, M., and Warr, G. A. Macrophage-derived factors increase low-density lipoprotein uptake and receptor number in cultured human liver cells. J. Lipid Res., 32: 1889-1897, 1991.
4. Horn, D., Fitzpatrick, W. C., Gompper, P. T., Ochs, V., Bolton-Hanson, M., Zarling, J., Malik, N., Todaro, G. J., and Linsley, P. S. Regulation of cell growth by recombinant oncostatin M. Growth Factors, 2: 157-165, 1990.
5. Grove, R. I., Eberhardt, C., Abid, S., Mazzucco, C., Liu, J., Todaro, G., Kiener, P., and Shoyab, M. Oncostatin M is a mitogen for rabbit vascular smooth muscle cells. Proc. Natl. Acad. Sci. USA, 90: 823-827, 1993.
6. Zhang, X. G., Gu, J. J., Lu, Z. Y., Yasukawa, K., Yancopoulos, G. D., Turner, K., Shoyab, M., Taga, T., Kishimoto, T., Bataille, R., and Klein, B. Ciliary neurotrophic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130. J. Exp. Med., 179: 1343-1347, 1994.
7. Lai, L., Kadory, S., Siraj, A. K., and Lennard, T. W. J. Oncostatin M, interleukin 2, interleukin 6, and interleukin 8 in breast cyst fluid. Int. J. Cancer, 59: 369-372, 1994.
8. Dixon, J. M., Lumsden, A. B., and Miller, W. R. The relationship of cyst type to risk factors for breast cancer in patients with breast cystic disease. Eur. J. Cancer Clin. Oncol., 21: 1047-1050, 1985.
9. Rose, T., and Bruce, A. G. Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony stimulating factor, and interleukin 6. Proc. Natl. Acad. Sci. USA, 88: 8641-8645, 1991.
10. Bazan, F. Neuropeptide cytokines in the hematopoietic fold. Neuron, 7: 197-208, 1991.
11. Stahl, N., and Yancopoulos, G. D. The alphas, betas, and kinases of cytokine receptor complexes. Cell, 74: 587-590, 1993.
12. Pennica, D., Shaw, K. J., Swanson, T. A., Moore, M. W., Shelton, D. L., Zioncheck, K. A., Rosenthal, A., Taga, T., Paoni, N. F., and Wood, W. I. Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex. J. Biol. Chem., 270: 10915-10922, 1995.
13. Gearing, D., and Bruce, A. G. Oncostatin M binds the high-affinity leukemia inhibitory factor. New Biol., 4: 61-65, 1991.
14. Gearing, D. P., Comeau, M. R., Friend, D. J., Gimpel, S., Thut, C. J., McGourty, J., Brasher, K. K., Kinh, J. A., Gillis, S., Mosley, B., Ziegler, S. F., and Coman, D. The 1L-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Science (Washington DC), 255: 1434-1437, 1992.
15. Liu, J., Modrell, B., Aruffo, A., Marken, J. S., Taga, T., Yasukawa, K., Murakami, M., Kishimoto, T., and Shoyab, M. Interleukin-6 signal transducer gp130 mediates oncostatin M signaling. J. Biol. Chem., 267: 16763-16766, 1992.
16. Liu, J., Modrell, B., Aruffo, A., Scharnowske, S., and Shoyab, M. Interactions between oncostatin M and the IL-6 signal transducer, gp130. Cytokine, 6: 272-278, 1994.
17. Mosley, B., Delmus, C., Friend, D., Thoma, B., and Cosman, D. The oncostatin M specific receptor: cloning of a novel subunit related to the LIF receptor. Cytokine, 6: 539, 1994.
18. Grove, R. I., Mazzucco, C. E., Radka, S. F., Shoyab, M., and Keiner, P. A. Oncostatin M upregulates low density lipoprotein uptake and receptors in HepG2 cells by a novel mechanism. J. Biol. Chem., 266: 18194-18199, 1991.
19. Brown, T. J., Rowe, J. M., and Shoyab, M. Regulation of interleukin-6 expression by oncostatin M. J. Immunol., 147: 2175-2180, 1991.
20. Hamilton, J. A., Leizer, T., Piccoli, D. S., Royston, K. M., Butler, D. M., and Croatto, M. Oncostatin M stimulates urokinase-type plasminogen activator activity in human synovial fibroblasts. Biochem. Biophys. Res. Commun., 180: 652-659, 1991.
21. Richards, C. D., Brown, T. J., Shoyab, M., Baumann, H., and Gauldie, J. Recombinant oncostatin M stimulates the production of acute phase proteins in hepatocytes in vitro. J. Immunol., 148: 1731-1736, 1992.
22. Liu, J., Clegg, C. H., and Shoyab, M. Regulation of EGR-1, c-jun, and c-myc gene expression by oncostatin M. Cell Growth & Differ., 3: 307-313, 1992.
23. Luscher, B., and Eisenman, R. N. New light on Myc and Myb. Part I. Myc. Genes Dev., 4: 2025-2035, 1990.
24. Zimmerman, K. A., and Alt, K. W. Expression and function of myc family genes. Crit. Rev. Oncog., 2: 75-95, 1990.
25. Berns, E. M., Klijn, J. G., van Stavern, I. L., Portengen, H., Noordegraaf, E., and Foekens, J. A. Prevalence of amplification of the oncogenes c-myc, HER2/neu. and int-2 in one thousand human breast tumours: correlation with steroid receptors. Eur. J. Cancer, 28: 697-700, 1992.
26. Roux-Dosseto, M., Romain, S., Dussault, N., Desideri, C., Piana, L., Bonnier, P., Tubiana, N., and Martin, P. M. c-myc gene amplification in selected node-negative breast cancer patients correlates with high rate of early relapse. Eur. J. Cancer, 28A: 1600-1604, 1992.
27. Malik, N., Graves, D., Shoyab, M., and Purchio, A. F. Amplification and expression of heterologous oncostatin M in Chinese hamster ovary cells. DNA Cell. Biol., 11: 453-459, 1992.
28. Peppel, K., and Baglioni, C. A simple and fast method to extract RNA from tissue culture cells. Biotechniques, 9: 711-713, 1990.
29. Maniatis, T., Fritsch, E. F., and Sambrook, J. Molecular Cloning: A Laboratory Manual, pp. 7.43-7.45. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1982.
30. Virca, G. D., Northemann, W., Shiels, B. R., Widera, G., and Broome, S. Simplified Northern blot hybridization using 5% sodium dodecyl sulfate. Biotechniques, 8: 370-371, 1990.
31. Greenberg, M. E., and Bender, T. P. Identification of newly transcribed RNA. In: F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (eds.), Current Protocols in Molecular Biology, pp. 4.10.1-4.10.4. New York: John Wiley & Sons, 1995.
32. Barone, M. V., and Courtneidge, S. A. Myc but not Fos rescue of PDGF signalling block caused by kinase-inactive Src. Nature (Lond.), 378: 509-512, 1995.
33. Kreipc, H., Feist, H., Fischer, L., Felgner, J., Heidorn, K., Mettler, and Parwaresch, R. Amplification of c-myc but not of erb-2 is associated with high proliferative capacity in breast cancer. Cancer Res., 53: 1956-1961, 1993.
34. Skerka, C., Zipfel, P. F., and Siebenlist, U. Two regulatory domains are required for down-regulation of c-myc transcription in differentiating U937 cells. Oncogene, 8: 2135-2143, 1993.
35. Moberg, K. H., Logan, T. J., Tyndall, W. A., and Hall, D. J. Three distinct elements within the murine c-myc promoter are required for transcription. Oncogene, 7: 411-421, 1992.
36. Pyrc, J. J., Moberg, K. H., and Hall, D. J. Isolation of a novel cDNA encoding a zinc-finger protein that binds to two sites within the c-myc promoter. Biochemistry, 31: 4102-4110, 1992.
37. Cogswell, J. P., Cogswell, P. C., Kuehl, W. M., Cuddihy, A. M., Bender, T. M., Engelke, U., Marcu, K. B., and Ting, J. P. Mechanism of c-myc down-regulation by c-Myb in different cell lineages. Mol. Cell. Biol., 13: 2858-2869, 1993.
38. Takimoto, M., Tomonaga, T., Matunis, M., Avigan, M., Krutzsch, H., Dreyfuss, G., and Levens, D. Specific binding of heterogeneous ribonucleoprotein particle protein K to the human c-myc promoter in vitro. J. Biol. Chem., 268: 18249-18258, 1993.
39. Duncan, R., Bazar, L., Michelotti, G., Tomonaga, T., Krutzsch, H., Avigan, M., and Levens, D. A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new DNA-binding motif. Genes Dev., 8: 465-480, 1994.
40. Roussel, M. F., Davis, J. N., Cleveland, J. L., Ghysdael, J., and Hiebert, S. W. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1. Oncogene, 9: 405-415, 1994.
41. Wolff, R. A., Dobrowsky, R. T., Bielawska, A., Obeid, L. M., and Hannun, Y. A. Role of ceramide-activated protein phosphatase in ceramide-mediated signal transduction. J. Biol. Chem., 269: 19605-19609, 1994.
42. Stewart, M. J., Litz-Jackson, S., Burgess, G. S., Williamson, E. A., Leibowitz, D. S., and Boswell, H. S. Role for E2F1 in p210 BCR-ABL downstream regulation of c-myc transcription initiation. Studies in murine myeloid cells. Leukemia (Baltimore), 9: 1499-1507, 1995.
43. Davis, S., Aldrich, T. H., Stahl, N., Pan, L., Taga, T., Kishimoto, T., Ip. N. Y., and Yancopoulos, G. D. LIFR β and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor. Science (Washington DC), 260: 1805-1808, 1993.
44. Thoma, B., Bird, T. A., Friend, D. J., Gearing, D. P., and Dower, S. K. Oncostatin M and leukemia inhibitory factor trigger overlapping and different signals through partially shared receptor complexes. J. Biol. Chem., 269: 6215-6222, 1994.
45. Boulton, T. G., Stahl, N., and Yancopoulos, G. D. Ciliary neurotrophic factor/ leukemia inhibitory factor/interleukin 6/oncostatin M family of cytokines induces tyrosine phosphorylation of a common set of proteins overlapping those induced by other cytokines and growth factors. J. Biol. Chem., 269: 11648-11655, 1994.
46. Feldman, G. M., Petricoin, E. F., III, David, M., Larner, A. C., and Finbloom, D. S. Cytokines that associate with the signal transducer gp130 activate the interferoninduced transcription factor p91 by tyrosine phosphorylation. J. Biol. Chem., 269: 10747-10752, 1994.
47. Ihle, J. N., Witthuhn, B. A., Quelle, F. W., Yamato, K., Thierfelder, W. E., Kreider, B., and Silvennoinen, O. Signaling by the cytokine receptor superfamily: JAKs and STATs. Trends Biochem. Sci., 19: 222-227, 1994.
48. Lutticken, C., Wegenka, U. M., Yuan, J., Buschmann, J., Schindler, C., Ziemiecki, A., Harpur, A. G., Wilks, A. F., Yasukawa, K., Taga, T., Kishimoto, T., Barbieri, G., Pellegrini, S., Sendtner, M., Heinrich, P. C., and Horn, F. Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130. Science (Washington DC), 263: 89-92, 1994.
49. Stahl, N., Boulton, T. G., Farruggella, T., Ip, N. Y., Davis, S., Witthuhn, B. A., Quelle, F. W., Silvennoinen, O., Barbieri, G., Pellegrini, S., Ihle, J. N., and Yancopoulos, G. D. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 β receptor components. Science (Washington DC), 263: 92-95, 1994.
50. Boulton, T. G., Zhong, Z., Wen, Z., Darnell, J. E., Jr., and Stahl, N. STAT3 activation by cytokines utilizing gp130 and related transducers involves a secondary modification requiring an H7-sensitive kinase. Proc. Natl. Acad. Sci. USA, 92: 6915-6919, 1995.
51. Stahl, N., Farruggella, T. J., Boulton, T. G., Zhong, Z., Darnell, J. E., Jr., and Yancopoulos, G. D. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science (Washington DC), 267: 1349-1353, 1995.